{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:05:45Z","timestamp":1781586345447,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.virusres.2020.198102","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:39:04Z","timestamp":1595590744000},"page":"198102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy"],"prefix":"10.1016","volume":"288","author":[{"given":"Taj","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleha","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Umair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Tabish","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed F.","family":"AlAjmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2020.198102_bib0005","doi-asserted-by":"crossref","DOI":"10.1063\/1.2945165","article-title":"Construction of the free energy landscape of biomolecules via dihedral angle principal component analysis","volume":"128","author":"Altis","year":"2008","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.virusres.2020.198102_bib0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/prot.340170408","article-title":"Essential dynamics of proteins","volume":"17","author":"Amadei","year":"1993","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"10.1016\/j.virusres.2020.198102_bib0015","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virusres.2020.198102_bib0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1389203715666140327114232","article-title":"A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states","volume":"15","author":"Ausaf Ali","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.virusres.2020.198102_bib0025","series-title":"Discovery Studio Modeling Environment","author":"Biovia","year":"2015"},{"issue":"10","key":"10.1016\/j.virusres.2020.198102_bib0030","first-page":"1007","article-title":"COVID-19: Therapeutics and their toxicities","volume":"16","author":"Chary","year":"2020","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.virusres.2020.198102_bib0035","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virusres.2020.198102_bib0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2020.198102_bib0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2020.198102_bib0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.virusres.2020.198102_bib0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2020.198102_bib0060","series-title":"Hydrogen Bonds in Proteins: Role and Strength","author":"Hubbard","year":"2001"},{"key":"10.1016\/j.virusres.2020.198102_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002499","article-title":"Accessible high-throughput virtual screening molecular docking software for students and educators","volume":"8","author":"Jacob","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.virusres.2020.198102_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.virusres.2020.198102_bib0075","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/acs.jnatprod.9b00372","article-title":"Identification of \u03b1-Mangostin as a potential inhibitor of microtubule affinity regulating kinase 4","volume":"82","author":"Khan","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.virusres.2020.198102_bib0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","article-title":"PASS: prediction of activity spectra for biologically active substances","volume":"16","author":"Lagunin","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virusres.2020.198102_bib0085","article-title":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS\u2010CoV\u20102","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2020.198102_bib0090","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining \u2018host jump\u2019of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virusres.2020.198102_bib0095","doi-asserted-by":"crossref","first-page":"e00818","DOI":"10.1128\/genomeA.00818-15","article-title":"Complete genome sequence of Middle East respiratory syndrome coronavirus (MERS-CoV) from the first imported MERS-CoV case in China","volume":"3","author":"Lu","year":"2015","journal-title":"Genome Announc."},{"key":"10.1016\/j.virusres.2020.198102_bib0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2020.198102_bib0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virusres.2014.08.001","article-title":"The SARS Coronavirus 3a protein binds calcium in its cytoplasmic domain","volume":"191","author":"Minakshi","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.virusres.2020.198102_bib0110","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/07391102.2018.1468282","article-title":"Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4)","volume":"37","author":"Mohammad","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.virusres.2020.198102_bib0115","first-page":"1","article-title":"Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer","author":"Mohammad","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.virusres.2020.198102_bib0120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2174\/1568026618666181025114157","article-title":"Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships","volume":"18","author":"Naqvi","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.virusres.2020.198102_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.virusres.2020.198102_bib0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijbiomac.2016.12.024","article-title":"Binding studies and biological evaluation of beta-carotene as a potential inhibitor of human calcium\/calmodulin-dependent protein kinase IV","volume":"96","author":"Naz","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virusres.2020.198102_bib0135","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.ijbiomac.2017.10.143","article-title":"Investigation of molecular mechanism of recognition between citral and MARK4: a newer therapeutic approach to attenuate cancer cell progression","volume":"107","author":"Naz","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virusres.2020.198102_bib0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.virusres.2020.198102_bib0145","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1021\/jo00094a033","article-title":"Syntheses of 6-Deaminosinefungin and (S)-6-Methyl-6-deaminosinefungin","volume":"59","author":"Peterli-Roth","year":"1994","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.virusres.2020.198102_bib0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/prot.20478","article-title":"Hydration of protein\u2013protein interfaces","volume":"60","author":"Rodier","year":"2005","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"10.1016\/j.virusres.2020.198102_bib0155","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201256","article-title":"Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy","volume":"40","author":"Shamsi","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.virusres.2020.198102_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2020.198102_bib0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.virusres.2020.198102_bib0170","first-page":"1","article-title":"Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: towards therapeutic management of Alzheimer\u2019s disease","author":"Turab Naqvi","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.virusres.2020.198102_bib0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2016.07.015","article-title":"MERS-CoV spike protein: targets for vaccines and therapeutics","volume":"133","author":"Wang","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2020.198102_bib0180","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2020.198102_bib0185","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virusres.2020.198102_bib0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2020.198102_bib0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virusres.2020.198102_bib0200","first-page":"1","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","author":"Zhou","year":"2020","journal-title":"Nature"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170220308856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170220308856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:09:46Z","timestamp":1759154986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170220308856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":40,"alternative-id":["S0168170220308856"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2020.198102","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2020.198102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198102"}}